Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Advancements in cell culture technology
3.2.1.2 Rising cell culture contamination
3.2.1.3 Increasing research and development activities
3.2.1.4 Increasing demand for fast, accurate, and affordable mycoplasma testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 Long and laborious detection process
3.2.2.2 Stringent regulatory scenario
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Kits and reagents
5.3.1 PCR (Polymerase chain reaction) assays
5.3.2 Nucleic acid detection kits
5.3.3 Stains
5.3.4 Elimination kits
5.3.5 Standards & controls
5.3.6 ELISA (Enzyme-linked immunosorbent assay) kits
5.3.7 Other kits and reagents
5.4 Services
Chapter 6 Market Estimates and Forecast, By Technique, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 PCR (Polymerase chain reaction)
6.3 ELISA (Enzyme-linked immunosorbent assay)
6.4 Microbial culturing technique
6.5 Enzymatic methods
6.6 Other techniques
Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Cell line testing
7.3 Virus testing
7.4 End of production cells testing
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Academic research institutes
8.3 Cell banks & laboratories
8.4 Contract research organizations
8.5 Pharmaceutical & biotechnology companies
8.6 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Becton, Dickinson, and Company (BD)
10.2 Bio-Rad Laboratories, Inc.
10.3 Charles River Laboratories International, Inc.
10.4 Creative Bioarray
10.5 Eurofins Scientific
10.6 InvivoGen
10.7 Lonza Group AG
10.8 Merck KGaA
10.9 Minerva Biolabs GmbH
10.10 PromoCell GmbH
10.11 QIAGEN N.V.
10.12 Sartorius AG
10.13 Thermo Fisher Scientific Inc.
